{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:55:56Z","timestamp":1761562556696,"version":"build-2065373602"},"reference-count":38,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100011949","name":"Abbott Vascular","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011949","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005035","name":"Biotronik","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005035","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014337","name":"Menarini Group","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008497","name":"Boston Scientific Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008497","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Revascularization Medicine"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.carrev.2019.02.017","type":"journal-article","created":{"date-parts":[[2019,2,28]],"date-time":"2019-02-28T02:34:21Z","timestamp":1551321261000},"page":"1075-1080","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Everolimus Eluting Stents in Patients with Diabetes Mellitus and Chronic Kidney Disease: Insights from the TUXEDO Trial"],"prefix":"10.1016","volume":"20","author":[{"given":"Sripal","family":"Bangalore","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajpal","family":"Abhaichand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ajit","family":"Mullasari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajneesh","family":"Jain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.K. Prem","family":"Chand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priyadarshini","family":"Arambam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Upendra","family":"Kaul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.carrev.2019.02.017_bb0005","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1038\/sj.ki.5001934","article-title":"The exclusion of patients with chronic kidney disease from clinical trials in coronary artery disease","volume":"70","author":"Charytan","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.carrev.2019.02.017_bb0010","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1007\/s00380-010-0110-4","article-title":"Efficacy of paclitaxel-eluting stent implantation in hemodialysis patients","volume":"26","author":"Higashitani","year":"2011","journal-title":"Heart Vessels"},{"key":"10.1016\/j.carrev.2019.02.017_bb0015","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.ijcard.2011.09.078","article-title":"Sirolimus- vs. paclitaxel-eluting stent to coronary intervention in dialysis patients","volume":"165","author":"Kamoi","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.carrev.2019.02.017_bb0020","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1161\/CIRCULATIONAHA.112.097014","article-title":"Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117 762 patient-years of follow-up from randomized trials","volume":"125","author":"Bangalore","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2019.02.017_bb0025","doi-asserted-by":"crossref","first-page":"f6625","DOI":"10.1136\/bmj.f6625","article-title":"Bare metal stents, durable polymer drug eluting stents, and biodegradable polymer drug eluting stents for coronary artery disease: mixed treatment comparison meta-analysis","volume":"347","author":"Bangalore","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.carrev.2019.02.017_bb0030","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1161\/CIRCULATIONAHA.113.005186","article-title":"Randomized comparison of xience v and multi-link vision coronary stents in the same multivessel patient with chronic kidney disease (renal-des) study","volume":"129","author":"Tomai","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2019.02.017_bb0035","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1056\/NEJMoa1510188","article-title":"Paclitaxel-eluting versus everolimus-eluting coronary stents in diabetes","volume":"373","author":"Kaul","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carrev.2019.02.017_bb0040","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","article-title":"Clinical end points in coronary stent trials: a case for standardized definitions","volume":"115","author":"Cutlip","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2019.02.017_bb0045","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/biomet\/70.1.41","article-title":"The central role of the propensity score in observational studies for causal effects","volume":"70","author":"Rosenbaum","year":"1983","journal-title":"Biometrika"},{"key":"10.1016\/j.carrev.2019.02.017_bb0050","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1023\/A:1020363010465","article-title":"Using propensity score to help design observational studies: application to the tobacco litigation","volume":"2","author":"Rubin","year":"2001","journal-title":"Health Serv Outcomes Res Methodol"},{"issue":"3","key":"10.1016\/j.carrev.2019.02.017_bb0055","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1016\/j.ijcard.2013.01.257","article-title":"Long-term benefits and risks of drug-eluting compared to bare-metal stents in patients with versus without chronic kidney disease","volume":"168","author":"Wanitschek","year":"2001","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.carrev.2019.02.017_bb0060","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/S0735-1097(02)02065-X","article-title":"Coronary atherosclerosis in diabetes mellitus: a population-based autopsy study","volume":"40","author":"Goraya","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2019.02.017_bb0065","doi-asserted-by":"crossref","first-page":"824","DOI":"10.7326\/0003-4819-139-10-200311180-00010","article-title":"Increased incidence of coronary atherosclerosis in type 2 diabetes mellitus: mechanisms and management","volume":"139","author":"Hurst","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.carrev.2019.02.017_bb0070","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1161\/01.CIR.0000089189.70578.E2","article-title":"Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part ii","volume":"108","author":"Luscher","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2019.02.017_bb0075","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.jacc.2006.09.045","article-title":"Coronary heart disease in patients with diabetes: part ii: recent advances in coronary revascularization","volume":"49","author":"Berry","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2019.02.017_bb0080","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/00019501-200208000-00003","article-title":"Mechanism of lumen gain during coronary stent deployment in diabetic patients compared with non-diabetic patients","volume":"13","author":"Syeda","year":"2002","journal-title":"Coron Artery Dis"},{"key":"10.1016\/j.carrev.2019.02.017_bb0085","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1161\/01.CIR.94.8.1818","article-title":"Coronary angioplasty in diabetic patients. The National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry","volume":"94","author":"Kip","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2019.02.017_bb0090","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1056\/NEJM199607253350401","article-title":"Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease","volume":"335","author":"The Bypass Angioplasty Revascularization Investigation (BARI) Investigators","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carrev.2019.02.017_bb0095","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.2337\/diacare.27.5.1137","article-title":"Effect of diabetes on long-term mortality following contemporary percutaneous coronary intervention: analysis of 4,284 cases","volume":"27","author":"Wilson","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.carrev.2019.02.017_bb0100","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/S0735-1097(98)00286-1","article-title":"The influence of diabetes mellitus on acute and late clinical outcomes following coronary stent implantation","volume":"32","author":"Abizaid","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2019.02.017_bb0105","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.2337\/diacare.27.7.1840","article-title":"Diabetes is still a risk factor for restenosis after drug-eluting stent in coronary arteries","volume":"27","author":"Scheen","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.carrev.2019.02.017_bb0110","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1016\/j.ehj.2004.07.041","article-title":"Drug-eluting stents: meta-analysis in diabetic patients","volume":"25","author":"Scheen","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1016\/j.carrev.2019.02.017_bb0115","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0002-9149(00)00998-X","article-title":"Impact of end-stage renal disease on clinical and angiographic outcomes after coronary stenting","volume":"86","author":"Azar","year":"2000","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.carrev.2019.02.017_bb0120","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/0002-8703(94)90476-6","article-title":"Complications and long-term outcome after percutaneous coronary angioplasty in chronic hemodialysis patients","volume":"128","author":"Ahmed","year":"1994","journal-title":"Am Heart J"},{"key":"10.1016\/j.carrev.2019.02.017_bb0125","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/S0735-1097(02)01745-X","article-title":"The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions","volume":"39","author":"Best","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2019.02.017_bb0130","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0002-9149(01)02163-4","article-title":"Comparison of outcomes after percutaneous coronary revascularization with stents in patients with and without mild chronic renal insufficiency","volume":"89","author":"Gruberg","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.carrev.2019.02.017_bb0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015070","article-title":"Drug-eluting stents in patients with chronic kidney disease: a prospective registry study","volume":"5","author":"Shenoy","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.carrev.2019.02.017_bb0140","first-page":"405","article-title":"Impact of drug-eluting stents on outcomes of patients with end-stage renal disease undergoing percutaneous coronary revascularization","volume":"18","author":"Das","year":"2006","journal-title":"J Invasive Cardiol"},{"key":"10.1016\/j.carrev.2019.02.017_bb0145","first-page":"577","article-title":"Clinical outcomes following percutaneous coronary intervention with drug-eluting vs. bare-metal stents in dialysis patients","volume":"18","author":"Halkin","year":"2006","journal-title":"J Invasive Cardiol"},{"key":"10.1016\/j.carrev.2019.02.017_bb0150","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1053\/j.ajkd.2009.01.263","article-title":"Clinical and angiographic outcomes following percutaneous coronary intervention with sirolimus-eluting stents versus bare-metal stents in hemodialysis patients","volume":"54","author":"Yachi","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.carrev.2019.02.017_bb0155","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1253\/circj.71.1525","article-title":"Impact of drug-eluting stents on clinical and angiographic outcomes in dialysis patients","volume":"71","author":"Ishio","year":"2007","journal-title":"Circ J"},{"key":"10.1016\/j.carrev.2019.02.017_bb0160","first-page":"291","article-title":"Clinical outcomes of dialysis patients after implantation of des: meta analysis and systematic review of literature","volume":"57","author":"Athappan","year":"2009","journal-title":"Minerva Cardioangiol"},{"key":"10.1016\/j.carrev.2019.02.017_bb0165","first-page":"22","article-title":"Percutaneous coronary intervention of moderate to severe calcified coronary lesions: insights from the National Heart, Lung and Blood Institute Dynamic Registry","volume":"77","author":"Bangalore","year":"2011","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2019.02.017_bb0170","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1161\/CIRCINTERVENTIONS.113.000415","article-title":"Outcomes with various drug-eluting or bare metal stents in patients with ST-segment-elevation myocardial infarction: a mixed treatment comparison analysis of trial level data from 34 068 patient-years of follow-up from randomized trials","volume":"6","author":"Bangalore","year":"2013","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2019.02.017_bb0175","doi-asserted-by":"crossref","first-page":"e5170","DOI":"10.1136\/bmj.e5170","article-title":"Outcomes with various drug eluting or bare metal stents in patients with diabetes mellitus: mixed treatment comparison analysis of 22 844 patient years of follow-up from randomised trials","volume":"345","author":"Bangalore","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.carrev.2019.02.017_bb0180","doi-asserted-by":"crossref","first-page":"830","DOI":"10.4070\/kcj.2012.42.12.830","article-title":"Coronary stents in patients with ST-elevation myocardial infarction and chronic kidney disease undergoing primary percutaneous coronary intervention","volume":"42","author":"Ahmed","year":"2012","journal-title":"Korean Circ J"},{"key":"10.1016\/j.carrev.2019.02.017_bb0185","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.biopha.2015.03.002","article-title":"Clinical outcomes of chronic kidney disease patients treated with everolimus-eluting stents (EES) and paclitaxel-eluting stents (PES)","volume":"72","author":"Kitasato","year":"2015","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.carrev.2019.02.017_bb0190","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.carrev.2015.04.005","article-title":"Comparison of everolimus- and paclitaxel-eluting stents in dialysis patients","volume":"16","author":"Otsuka","year":"2015","journal-title":"Cardiovasc Revasc Med"}],"container-title":["Cardiovascular Revascularization Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838919301502?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838919301502?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:15:58Z","timestamp":1761560158000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1553838919301502"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":38,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["S1553838919301502"],"URL":"https:\/\/doi.org\/10.1016\/j.carrev.2019.02.017","relation":{},"ISSN":["1553-8389"],"issn-type":[{"type":"print","value":"1553-8389"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Everolimus Eluting Stents in Patients with Diabetes Mellitus and Chronic Kidney Disease: Insights from the TUXEDO Trial","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Revascularization Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carrev.2019.02.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}